We successfully articulate the exceptional stories of small- and mid-cap companies to the Wall Street investor community.
We compile and disseminate objective, factual information for both institutional and retail investor audiences that capitalizes on an expansive line of targeted distribution channels.
Our distribution efforts are accompanied by prominent social media channels and strategic and targeted appearances on national news programs and print media.
Our products are prominently published and available on well-known financial forums, including Bloomberg, Thomson Reuters/First Call, S&P Capital IQ, FactSet, Yahoo! Finance, and others.
Our firm is led by Wall Street veterans, Jeffrey Kraws and Karen Goldfarb, who have built a unique business model, capitalizing on decades of experience as an award-winning sell-side analyst team.
NEW Research: SG Blocks, Inc.(SGBX-NASDAQ)
NEW Research: Bioxytran, Inc.(BIXT-OTCBB)
NEW Research: Genprex, Inc.(GNPX-NASDAQ)
NEW Research: ImmunoPrecise Antibodies Ltd(IPA-NASDAQ/IPA-TSX)
NEW Research: FSD Pharma Inc.(HUGE-NASDAQ, HUGE-CSE)
NEW Research: Victory Square Technologies Inc. (VSQTF-OTCQX, VST-CSE)
NEW Research: Emerald Health Pharmaceuticals Inc. (PRIVATE)
NEW Research:GeoVax Labs, Inc.(GOVX-OTC)
IN THE MEDIA
FIND US ONLINE
880 Third Avenue, 6th Floor
New York, NY 10022
Phone: (212) 851-6685